UBS AM’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-18,226
| Closed | -$171K | – | 2614 |
|
|
2020
Q3 | $171K | Sell |
18,226
-15,482
| -46% | -$146K | ﹤0.01% | 2420 |
|
|
2020
Q2 | $258K | Sell |
33,708
-8,517
| -20% | -$65.2K | ﹤0.01% | 2329 |
|
|
2020
Q1 | $261K | Sell |
42,225
-921
| -2% | -$5.69K | ﹤0.01% | 2195 |
|
|
2019
Q4 | $525K | Buy |
43,146
+2,084
| +5% | +$25.4K | ﹤0.01% | 2217 |
|
|
2019
Q3 | $474K | Buy |
41,062
+14,087
| +52% | +$163K | ﹤0.01% | 2316 |
|
|
2019
Q2 | $269K | Buy |
26,975
+14,876
| +123% | +$149K | ﹤0.01% | 2444 |
|
|
2019
Q1 | $156K | Hold |
12,099
| – | – | ﹤0.01% | 2519 |
|
|
2018
Q4 | $184K | Hold |
12,099
| – | – | ﹤0.01% | 2411 |
|
|
2018
Q3 | $242K | Hold |
12,099
| – | – | ﹤0.01% | 2357 |
|
|
2018
Q2 | $236K | Hold |
12,099
| – | – | ﹤0.01% | 2407 |
|
|
2018
Q1 | $244K | Buy |
+12,099
| New | +$244K | ﹤0.01% | 2302 |
|
|
2017
Q1 | – | Sell |
-8,199
| Closed | -$285K | – | 2504 |
|
|
2016
Q4 | $285K | Sell |
8,199
-8,457
| -51% | -$294K | ﹤0.01% | 1963 |
|
|
2016
Q3 | $408K | Hold |
16,656
| – | – | ﹤0.01% | 2098 |
|
|
2016
Q2 | $398K | Buy |
16,656
+3,200
| +24% | +$76.5K | ﹤0.01% | 2078 |
|
|
2016
Q1 | $315K | Sell |
13,456
-800
| -6% | -$18.7K | ﹤0.01% | 2188 |
|
|
2015
Q4 | $430K | Hold |
14,256
| – | – | ﹤0.01% | 2137 |
|
|
2015
Q3 | $566K | Buy |
14,256
+3,457
| +32% | +$137K | ﹤0.01% | 1957 |
|
|
2015
Q2 | $746K | Buy |
10,799
+2,200
| +26% | +$152K | ﹤0.01% | 1835 |
|
|
2015
Q1 | $470K | Buy |
8,599
+2,300
| +37% | +$126K | ﹤0.01% | 2006 |
|
|
2014
Q4 | $268K | Hold |
6,299
| – | – | ﹤0.01% | 2301 |
|
|
2014
Q3 | $201K | Buy |
+6,299
| New | +$201K | ﹤0.01% | 2382 |
|